Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-18
2005-01-18
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S302000, C514S303000, C514S252010, C514S253030, C514S352000
Reexamination Certificate
active
06844354
ABSTRACT:
An agent for the prophylaxis and treatment of interstitial pneumonia and pulmonary fibrosis, which contains a compound having a Rho kinase inhibitory activity, particularly an agent for the prophylaxis and treatment of interstitial pneumonia and pulmonary fibrosis, which contains a compound of the formula (I)wherein each symbol is as defined in the specification, as the compound having a Rho kinase inhibitory activity, is provided.
REFERENCES:
patent: 5880156 (1999-03-01), Lang et al.
patent: 5906819 (1999-05-01), Kaibuchi et al.
patent: 519354 (1992-12-01), None
patent: 0 519 354 (1992-12-01), None
patent: 784980 (1997-07-01), None
patent: 0 784 980 (1997-07-01), None
patent: 893437 (1999-01-01), None
patent: 0 893 437 (1999-01-01), None
patent: 0 956 865 (1999-11-01), None
patent: 61-158983 (1986-07-01), None
patent: 2-290821 (1990-11-01), None
patent: 6-345643 (1994-12-01), None
patent: 10-113187 (1998-05-01), None
patent: 10-218768 (1998-08-01), None
patent: 9806433 (1998-02-01), None
patent: 98-47892 (1998-10-01), None
patent: 0009162 (2000-02-01), None
Database BIOSIS Online abstract of Kunitake et al., “Expression of p53, p21 (Waf1/Cip1/Sdi1) and Fas antigen in collagen vascular and granulamatous lung diseases”, European Respiratory Journal, vol. 12, No. 4, Oct., 1998.
Database BIOSIS Online abstract of Kuwano Kazuyoshi et al., “P21-Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis”, American Journal of Respiratory and Critical Care Medicine, vol. 154, No. 2, part 1, 1996, pp. 477-483.
Database BIOSIS Online abstract of Rauf Brandt et al., “Serum Oncoproteins and Growth Factors in Asbestosis and Silicosis Patients”, International Journal of Cancer, vol. 50, No. 6, 1992, pp. 881-885.
Database BIOSIS Online abstract of K. Kawano et al., “The roles of apoptosis in lung injury and fibrosis”, Journal of the Japanese Respiratory Society, vol. 36, No. 9., Sep. 1998, pp. 739-744.
Dobashi Kunio
Iizuka Kunihiko
Uehata Masayoshi
Dentz Bernard
Mitsubishi Pharma Corporation
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Agent for prophylaxis and treatment of interstitial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for prophylaxis and treatment of interstitial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for prophylaxis and treatment of interstitial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3438792